← Back to Search

Learning Strategies for Autism

N/A

Waitlist Available

Research Sponsored by New York University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Must not have

born premature (< 36 weeks)

has uncorrected hearing or vision impairments

Timeline

Screening 3 weeks

Treatment Varies

Follow Up during test phase of the experimental session (e.g., within 5 seconds)

Awards & highlights

No Placebo-Only Group

Summary

This trial is testing whether children with ASD can learn new words by overhearing conversations.

Who is the study for?

This study is for children aged 24 to 71 months who either have Autism Spectrum Disorder or are typically developing. They must have a minimum language and nonverbal cognition age of 24 months, speak English as their native language, and not be born prematurely (<36 weeks). Children with uncorrected hearing or vision issues, photosensitive epilepsy, or other cognitive-impacting conditions besides ASD (except ADHD) cannot participate.

What is being tested?

The trial investigates if children with ASD can learn verbs and pronouns from overheard conversations compared to typically developing children. It aims to understand how these kids process words that aren't just object labels when they're not directly involved in the conversation.

What are the potential side effects?

Since this study involves observational learning without medical interventions, there are no direct side effects associated with drugs or treatments. However, participation may involve typical risks of psychological research such as discomfort from sitting still during sessions.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I was born before 36 weeks of pregnancy.

Select...

I have hearing or vision problems that haven't been corrected.

Select...

I have had seizures triggered by flashing lights.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ during test phase of the experimental session (e.g., within 5 seconds)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~during test phase of the experimental session (e.g., within 5 seconds)

This trial's timeline: 3 weeks for screening, Varies for treatment, and during test phase of the experimental session (e.g., within 5 seconds) for reporting.